Results 91 to 100 of about 4,675 (154)

Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain.

, 2014
Persistent pain affects nearly half of all people seeking medical care in the US alone, and accounts for at least $80 billion worth of lost productivity each year.
Costa B, Skaper SD, Fusco M, Della Valle MF, FACCI, LAURA, GIUSTI, PIETRO, ZUSSO, MORENA   +6 more
core   +1 more source

Therapeutic Potential of Palmitoylethanolamide in Gastrointestinal Disorders

Antioxidants
Palmitoylethanolamide (PEA) is an endocannabinoid-like bioactive lipid mediator belonging to the family of N-acylethanolamines, most abundantly found in peanuts and egg yolk. When the gastrointestinal (GI) effects of PEA are discussed, it must be pointed
Marija Branković, Tijana Gmizić, Marija Dukić, Marija Zdravković, Branislava Daskalović, Davor Mrda, Novica Nikolić, Milica Brajković, Milan Gojgić, Jovana Lalatović, Đorđe Kralj, Ivana Pantić, Marko Vojnović, Tamara Milovanović, Siniša Đurašević, Zoran Todorović   +15 more
doaj   +1 more source

The calcineurin inhibitor ciclosporine and palmitoylethanolamide potentiate the sensory nerve-dependent vasodilator response to 2-arachidonoylglycerol.

, 2013
Effects of ciclosporine (A) and palmitoylethanolamide (PEA, B) on the vasorelaxation evoked by 2-arachidonoylglycerol (2-AG) in rat isolated mesenteric arterial segments.
Peter M. Zygmunt (241661), Anna Ermund (241659), Bryndis Birnir (113570), Alain Eschalier (209750), Stuart Bevan (303154), Bo A. G. Jönsson (241660), Edward D. Högestätt (241662), Charlotte Simonsen (441655), Pouya Movahed (491625), Christophe Mallet (241657), David A. Andersson (303152), Ana Gomis (491626), Anders Blomgren (441654)   +12 more
core   +1 more source

Editorial: New challenges and future perspectives in pathological conditions

Frontiers in Behavioral Neuroscience, 2023
Mustapha Muzaimi, K. N. Bhanu Prakash, Pike See Cheah, Linqing Feng, Linqing Feng   +4 more
doaj   +1 more source

Anti-inflammatory Formulations And Uses Thereof Including A Combination Of Palmitoylethanolamide And Plant-based Polyphenols

, 2019
Pharmaceutical or nutraceutical formulations are provided for treating inflammation in a subject in need thereof, as well as methods of treating inflammation in a subject in need thereof by administering one of the formulations.
Mertens-Talcott, Susanne U., Thomas, Ariela Betsy, Pfeifer, Geoffrey R., Venancio, Vinicius De Paula, Ebersole, Blake M.   +4 more
core   +1 more source

RETRACTED: Peritore et al. Ultramicronized Palmitoylethanolamide and Paracetamol, a New Association to Relieve Hyperalgesia and Pain in a Sciatic Nerve Injury Model in Rat. <i>Int. J. Mol. Sci.</i> 2020, <i>21</i>, 3509. [PDF]

Int J Mol Sci
Peritore AF, Siracusa R, Fusco R, Gugliandolo E, D'Amico R, Cordaro M, Crupi R, Genovese T, Impellizzeri D, Cuzzocrea S, Paola RD.   +10 more
europepmc   +1 more source

Palmitoylethanolamide and Luteolin in Brain Aging and Cognitive Decline: Biological Rationale and Current Evidence. [PDF]

Nutrients
Mancinetti F, Boccardi V, Valenza M, Alunno M, Scamosci M, Facchinetti R, Tecchio V, Guazzarini AG, Procaccini M, Cari L, Nocentini G, Ruggiero C, Scuderi C, Steardo L, Mecocci P.   +14 more
europepmc   +1 more source

Water-Dispersible Palmitoylethanolamide (PEA) Supplementation for Functional Improvement in Adults With Chronic Sciatica-Related Back Pain: A Pilot Clinical Trial. [PDF]

Cureus
Raju HN, Subramanian D, Russo R.
europepmc   +1 more source

Regulation of Cholesterol and Triglyceride Metabolism by Fatty acid Ethanolamides. [PDF]

Curr Atheroscler Rep
Davies SS, Fadaei R.
europepmc   +1 more source

Activation of human brown adipocytes alters the plasma fatty acid profile. [PDF]

Front Mol Biosci
Miniewska K, Mojsak P, Chmielewska S, Choinska P, Godzien J, Labieniec L, Andrejczuk A, Hannukainen J, Oikonen V, Virtanen K, Nuutila P, Ciborowski M, Maliszewska K, Kretowski AJ.   +13 more
europepmc   +1 more source